These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 3879122

  • 1. Monitoring treatment in congenital adrenal hyperplasia. Use of serial measurements of 17-OH-progesterone in plasma, capillary blood, and saliva.
    Hughes IA, Dyas J, Robinson J, Walker RF, Fahmy DR.
    Ann N Y Acad Sci; 1985; 458():193-202. PubMed ID: 3879122
    [No Abstract] [Full Text] [Related]

  • 2. Modern medical therapy of congenital adrenal hyperplasia. A decade of experience.
    Winter JS, Couch RM.
    Ann N Y Acad Sci; 1985; 458():165-73. PubMed ID: 3879120
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical assessment of the role of circadian rhythm of hormone contents in the blood and saliva of children with congenital dysfunction of the adrenal cortex].
    Fofanova OV.
    Pediatriia; 1989; (11):38-41. PubMed ID: 2608371
    [Abstract] [Full Text] [Related]

  • 4. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O, Shimura N, Nakayama Y, Arisaka M, Yabuta K.
    Dtsch Med Wochenschr; 1988 Dec 09; 113(49):1913-5. PubMed ID: 3197614
    [Abstract] [Full Text] [Related]

  • 5. Salivary 17 alpha-hydroxyprogesterone in congenital adrenal hyperplasia.
    Walker RF, Hughes IA, Riad-Fahmy D.
    Clin Endocrinol (Oxf); 1979 Dec 09; 11(6):631-7. PubMed ID: 535169
    [No Abstract] [Full Text] [Related]

  • 6. [Methodical approaches to the determination of steroid hormone levels in different biological fluids in children with congenital dysfunction of the adrenal cortex].
    Fofanova OV, Pankova SS, Kolesnikova GS.
    Pediatriia; 1989 Dec 09; (11):72-5. PubMed ID: 2608377
    [Abstract] [Full Text] [Related]

  • 7. Simultaneous plasma and saliva steroid measurements as an index of control in congenital adrenal hyperplasia (CAH). A longitudinal study.
    Hughes IA, Read GF.
    Horm Res; 1982 Dec 09; 16(3):142-50. PubMed ID: 7106699
    [Abstract] [Full Text] [Related]

  • 8. Congenital adrenal hyperplasia and luteal dysfunction.
    Villanueva AL, Rebar RW.
    Int J Gynaecol Obstet; 1985 Dec 09; 23(6):449-54. PubMed ID: 2868937
    [Abstract] [Full Text] [Related]

  • 9. [Radioimmunoassay of salivary l7 alpha-hydroxyprogesterone. Values obtained in healthy subjects and in patients treated for congenital hyperplasia of the adrenal glands].
    Guechot J, Fiet J, Gourmelen M, Pham-Huu-Trung MT, Raux-Eurin MC, Brerault JL, Gueux B, Villette JM.
    Ann Biol Clin (Paris); 1985 Dec 09; 43(4):333-7. PubMed ID: 4091295
    [Abstract] [Full Text] [Related]

  • 10. Response to treatment of congenital adrenal hyperplasia in infancy.
    Young MC, Hughes IA.
    Arch Dis Child; 1990 Apr 09; 65(4):441-4. PubMed ID: 2346339
    [Abstract] [Full Text] [Related]

  • 11. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements.
    Hughes IA, Read GF.
    Horm Res; 1984 Apr 09; 19(2):77-85. PubMed ID: 6538545
    [Abstract] [Full Text] [Related]

  • 12. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE, Sizonenko PC.
    Arch Fr Pediatr; 1985 Mar 09; 42(3):211-7. PubMed ID: 4004483
    [Abstract] [Full Text] [Related]

  • 13. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency.
    David M, Forest MG.
    J Pediatr; 1984 Nov 09; 105(5):799-803. PubMed ID: 6334149
    [Abstract] [Full Text] [Related]

  • 14. [Virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: early diagnosis and response to 2 treatment schedules].
    Cattani A, Mahaha D, Michaud P, Rodríguez JA, López JM, García H, Foradori A, Velásquez CG.
    Rev Chil Pediatr; 1984 Nov 09; 55(6):374-9. PubMed ID: 6536989
    [No Abstract] [Full Text] [Related]

  • 15. [Congenital virilizing adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Study of eleven cases (author's transl)].
    Dunand A, Roger M, Chaussain JL, Nocton F, Job JC.
    Sem Hop; 1984 Nov 09; 57(33-36):1392-7. PubMed ID: 6270798
    [Abstract] [Full Text] [Related]

  • 16. [New concepts in virilizing adrenal hyperplasia caused by 21-hydroxylase block].
    Cortínez A, Beas F, Devoto L, Henríquez C.
    Rev Chil Pediatr; 1985 Nov 09; 56(3):192-8. PubMed ID: 3879364
    [No Abstract] [Full Text] [Related]

  • 17. [Determination of 17-hydroxyprogesterone levels in the treatment of children with the adrenogenital syndrome].
    Vavrinec J, Dvorák P, Zizkovský V, Kopecký A, Pospísilová D, Starý J.
    Cesk Pediatr; 1983 Sep 09; 38(9):533-6. PubMed ID: 6315246
    [No Abstract] [Full Text] [Related]

  • 18. Bloodspot 17 alpha-hydroxyprogesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy.
    Riordan FA, Wood PJ, Wakelin K, Betts P, Clayton BE.
    Lancet; 1984 Mar 31; 1(8379):708-11. PubMed ID: 6143043
    [Abstract] [Full Text] [Related]

  • 19. Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Pang S, Pollack MS, Loo M, Green O, Nussbaum R, Clayton G, Dupont B, New MI.
    Ann N Y Acad Sci; 1985 Mar 31; 458():111-29. PubMed ID: 3879117
    [No Abstract] [Full Text] [Related]

  • 20. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Pang SY, Pollack MS, Marshall RN, Immken L.
    N Engl J Med; 1990 Jan 11; 322(2):111-5. PubMed ID: 2403652
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.